All News

05:07pm Betting on Restraint Zonebourse
01:46pm Pharma sector doubles down on AI amid hopes of slashing costs, timelines RE
12:53pm GSK : Gets a Neutral rating from Deutsche Bank ZD
11:44am GSK : Barclays remains a Sell rating ZD
10:06am The V for victory, at least on the charts Zonebourse
04-14 LIXTE Biotechnology Holdings, Inc. Presents Favorable Results For LB-100 And Dostarlimab Combination In Ovarian Cancer Study CI
04-13 European Stocks Fall in Monday Trading After US-Iran Peace Talks Collapse MT
04-13 Earnings Season in Trump's Shadow Zonebourse
04-13 NRx Pharmaceuticals, Inc. Announces Appointment of Glenn Tyson as Chief Commercial Officer CI
04-13 Bioversys Ag Publishes Pre-Clinical Data of Alpe Drug Combination in Nature Communications CI
04-13 GSK : JP Morgan maintains a Sell rating ZD
04-13 GSK : Jefferies gives a Buy rating ZD
04-13 GSK Reports Phase I Trial Data for Mocertatug Rezetecan in Gynaecological Cancers MT
04-13 Bernstein cuts Wizz Air and easyJet AN
04-13 GSK : Goldman Sachs remains Neutral ZD
04-13 European shares poised to open lower as Middle East talks fail RE
04-13 Washington raises the stakes Zonebourse
04-13 GSK posts encouraging data for endometrial and ovarian cancer drug AN
04-13 UK Stocks-Factors to watch on April 13 RE
04-13 GSK Logs Positive Data in Gynecological Cancers Drug Trial MT
04-13 PRESS DIGEST-Financial Times - April 13 RE
04-12 GSK : presents positive data for B7-H4-targeted ADC in gynaecological cancers PU
04-12 GSK sees blockbuster potential in targeted cancer therapy after promising early data RE
04-10 European Stocks Tracking Higher in Friday Trading Amid US-Iran Ceasefire Talks; German Inflation Rises in March MT
04-10 Alert on Viiv Healthcare launching a PSA withdrawn RE
No results for this search